{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Configuration dictionary\n",
    "WEAVIATE_PROD_CONF = {\n",
    "  \"http_host\": \"weaviate-new.eu-more-europa-gpu.quinten.io\",\n",
    "  \"http_port\": 443,\n",
    "  \"http_secure\": True,\n",
    "  \"grpc_host\": \"10.23.3.69\",\n",
    "  \"grpc_port\": 3051,\n",
    "  \"grpc_secure\": False,\n",
    "  \"skip_init_checks\": True,\n",
    "}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "import weaviate\n",
    "weaviate_client = weaviate.connect_to_custom(**WEAVIATE_PROD_CONF)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "# python pretty print\n",
    "from pprint import pprint\n",
    "\n",
    "prod_collections = weaviate_client.collections.list_all()\n",
    "# pprint(prod_collections)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{\n",
      "  \"object_id\": \"00003009-e600-5ef0-9317-79db805dd458\",\n",
      "  \"outcome_measure\": \"Admission hyperglycemia, stroke subtypes, and early vascular outcomes (3-month stroke, all-cause mortality, and composite of stroke, myocardial infarction, and all-cause mortality)\",\n",
      "  \"comparator\": \"Not specified\",\n",
      "  \"registry_related\": true,\n",
      "  \"geographical_area\": [\n",
      "    \"Not specified\"\n",
      "  ],\n",
      "  \"intervention\": \"Not specified\",\n",
      "  \"publishing_date\": \"2023-02-01T00:00:00+00:00\",\n",
      "  \"abstract\": \"Whether admission hyperglycemia is differentially associated with early vascular outcomes in acute ischemic stroke (AIS) depending on stroke subtype has been incompletely delineated. In a multicenter, prospective stroke registry, patients with AIS were categorized based on admission glucose levels into normoglycemia, moderate hyperglycemia, and severe hyperglycemia (<140mg/dl, 140-179mg/dl, and\\u00a0\\u2265180mg/dl, respectively) groups. Multivariate analysis assessed the interaction between the hyperglycemia and ischemic stroke subtypes of large artery atherothrombosis (LAA), cardioembolism (CE), and small vessel occlusion (SVO) and early vascular outcomes (3-month stroke, all-cause mortality, and composite of stroke, MI, and all-cause mortality). Among the 32,772 patients (age:69.0\\u00b112.6yrs, male:58.4%) meeting eligibility criteria, 61.9% were in the normoglycemia group, 19.5% were in the moderate hyperglycemia group, and 18.7% were in the severe hyperglycemia group. Substantial interactions between hyperglycemia groups and stroke subtypes were observed for 3-month stroke (P Hyperglycemia was differently associated with the risk of 3-month stroke by ischemic stroke subtype. The associations of hyperglycemia with 3-month stroke were greatest in CE subtype but not in SVO subtype. These results suggest that the effect of glucose-lowering treatment after AIS may differ according to stroke subtype.\",\n",
      "  \"population_follow_up\": \"3 months\",\n",
      "  \"design_model_description\": \"This is a multicenter, prospective stroke registry study\",\n",
      "  \"data_source_name\": \"not specified\",\n",
      "  \"redirection_link\": \"https://pubmed.ncbi.nlm.nih.gov/36642337\",\n",
      "  \"population_sex\": [\n",
      "    \"Male\",\n",
      "    \"Female\"\n",
      "  ],\n",
      "  \"journal\": null,\n",
      "  \"design_model\": \"Cohort studies\",\n",
      "  \"summary\": null,\n",
      "  \"keywords\": [\n",
      "    \"Acute Ischemic Stroke\",\n",
      "    \"Admission Hyperglycemia\",\n",
      "    \"Early Vascular Outcome\",\n",
      "    \"Stroke Subtype\"\n",
      "  ],\n",
      "  \"chemicals\": [\n",
      "    \"Glucose\"\n",
      "  ],\n",
      "  \"pmid\": \"36642337\",\n",
      "  \"population_age_group\": [\n",
      "    \"Adult\"\n",
      "  ],\n",
      "  \"retrieved_from\": [\n",
      "    \"PubMed\"\n",
      "  ],\n",
      "  \"authors\": [\n",
      "    \"Joon-Tae Kim\",\n",
      "    \"Ji Sung Lee\",\n",
      "    \"Beom Joon Kim\",\n",
      "    \"Jihoon Kang\",\n",
      "    \"Keon-Joo Lee\",\n",
      "    \"Jong-Moo Park\",\n",
      "    \"Kyusik Kang\",\n",
      "    \"Soo Joo Lee\",\n",
      "    \"Jae Guk Kim\",\n",
      "    \"Jae-Kwan Cha\",\n",
      "    \"Dae-Hyun Kim\",\n",
      "    \"Tai Hwan Park\",\n",
      "    \"Kyung Bok Lee\",\n",
      "    \"Jun Lee\",\n",
      "    \"Keun-Sik Hong\",\n",
      "    \"Yong-Jin Cho\",\n",
      "    \"Hong-Kyun Park\",\n",
      "    \"Byung-Chul Lee\",\n",
      "    \"Kyung-Ho Yu\",\n",
      "    \"Mi Sun Oh\",\n",
      "    \"Dong-Eog Kim\",\n",
      "    \"Jay Chol Choi\",\n",
      "    \"Jee-Hyun Kwon\",\n",
      "    \"Wook-Joo Kim\",\n",
      "    \"Dong-Ick Shin\",\n",
      "    \"Kyu Sun Yum\",\n",
      "    \"Sung Il Sohn\",\n",
      "    \"Jeong-Ho Hong\",\n",
      "    \"Sang-Hwa Lee\",\n",
      "    \"Man-Seok Park\",\n",
      "    \"Kang-Ho Choi\",\n",
      "    \"Wi-Sun Ryu\",\n",
      "    \"Juneyoung Lee\",\n",
      "    \"Jeffrey L Saver\",\n",
      "    \"Hee-Joon Bae\"\n",
      "  ],\n",
      "  \"category\": \"Publication refering to a registry\",\n",
      "  \"pdf_link\": null,\n",
      "  \"title\": \"Admission hyperglycemia, stroke subtypes, outcomes in acute ischemic stroke.\",\n",
      "  \"medical_condition\": [\n",
      "    \"Acute ischemic stroke\"\n",
      "  ],\n",
      "  \"population_size\": 32772,\n",
      "  \"mesh_terms\": [\n",
      "    \"Humans\",\n",
      "    \"Male\",\n",
      "    \"Middle Aged\",\n",
      "    \"Aged\",\n",
      "    \"Aged, 80 And Over\",\n",
      "    \"Ischemic Stroke\",\n",
      "    \"Brain Ischemia\",\n",
      "    \"Stroke\",\n",
      "    \"Hyperglycemia\",\n",
      "    \"Glucose\"\n",
      "  ],\n",
      "  \"population_description\": \"Patients with acute ischemic stroke (AIS)\"\n",
      "}\n",
      "{\n",
      "  \"object_id\": \"0000572b-fd58-5db3-b3b5-56e70f2098b5\",\n",
      "  \"outcome_measure\": \"Clinical criteria to classify and stratify patients according to their disease severity, identification of clinical criteria that would allow an effective classification of adult patients, a new score that allows the severity stratification of patients\",\n",
      "  \"comparator\": \"Not specified\",\n",
      "  \"registry_related\": true,\n",
      "  \"geographical_area\": [\n",
      "    \"France\"\n",
      "  ],\n",
      "  \"intervention\": \"Not specified\",\n",
      "  \"publishing_date\": \"2020-01-01T00:00:00+00:00\",\n",
      "  \"abstract\": \"Fabry disease (OMIM #301 500), the most prevalent lysosomal storage disease, is caused by enzymatic defects in alpha-galactosidase A (GLA gene; Xq22.1). Fabry disease has historically been characterized by progressive renal failure, early stroke and hypertrophic cardiomyopathy, with a diminished life expectancy. A nonclassical phenotype has been described with an almost exclusive cardiac involvement. Specific therapies with enzyme substitution or chaperone molecules are now available depending on the mutation carried. Numerous clinical and fundamental studies have been conducted without stratifying patients by phenotype or severity, despite different prognoses and possible different pathophysiologies. We aimed to identify a simple and clinically relevant way to classify and stratify patients according to their disease severity. Based on data from the French Fabry Biobank and Registry (FFABRY; n = 104; 54 males), we applied unsupervised multivariate statistics to determine clusters of patients and identify clinical criteria that would allow an effective classification of adult patients. Thanks to these criteria and empirical clinical considerations we secondly elaborate a new score that allow the severity stratification of patients. We observed that the absence of acroparesthesia or cornea verticillata is sufficient to classify males as having the nonclassical phenotype. We did not identify criteria that significantly cluster female patients. The classical phenotype was associated with a higher risk of severe renal (HR = 35.1; p <10-3) and cardiac events (HR = 4.8; p = 0.008) and a trend toward a higher risk of severe neurological events (HR = 7.7; p = 0.08) compared to nonclassical males. Our simple, rapid and clinically-relevant FFABRY score gave concordant results with the validated MSSI. Acroparesthesia and cornea verticillata are simple clinical criteria that efficiently stratify Fabry patients, defining 3 different groups: females and males with nonclassical and classical phenotypes of significantly different severity. The FFABRY score allows severity stratification of Fabry patients.\",\n",
      "  \"data_source_name\": \"French Fabry Biobank and Registry (FFABRY)\",\n",
      "  \"design_model_description\": \"Observational studies\",\n",
      "  \"population_follow_up\": \"Not specified\",\n",
      "  \"journal\": \"PLoS ONE\",\n",
      "  \"population_sex\": [\n",
      "    \"Male\",\n",
      "    \"Female\"\n",
      "  ],\n",
      "  \"redirection_link\": \"https://pubmed.ncbi.nlm.nih.gov/32442237\",\n",
      "  \"design_model\": \"Cohort studies\",\n",
      "  \"summary\": null,\n",
      "  \"keywords\": [],\n",
      "  \"chemicals\": [],\n",
      "  \"population_age_group\": [\n",
      "    \"Adult\"\n",
      "  ],\n",
      "  \"pmid\": \"32442237\",\n",
      "  \"authors\": [\n",
      "    \"Wladimir Mauhin\",\n",
      "    \"Olivier Benveniste\",\n",
      "    \"Damien Amelin\",\n",
      "    \"Cl\\u00e9mence Montagner\",\n",
      "    \"Foudil Lamari\",\n",
      "    \"Catherine Caillaud\",\n",
      "    \"Claire Douillard\",\n",
      "    \"Bertrand Dussol\",\n",
      "    \"Vanessa Leguy-Seguin\",\n",
      "    \"Pauline D'Halluin\",\n",
      "    \"Esther Noel\",\n",
      "    \"Thierry Zenone\",\n",
      "    \"Marie Matignon\",\n",
      "    \"Fran\\u00e7ois Maillot\",\n",
      "    \"Kim-Heang Ly\",\n",
      "    \"G\\u00e9rard Besson\",\n",
      "    \"Marjolaine Willems\",\n",
      "    \"Fabien Labombarda\",\n",
      "    \"Agathe Masseau\",\n",
      "    \"Christian Lavigne\",\n",
      "    \"Didier Lacombe\",\n",
      "    \"H\\u00e9l\\u00e8ne Maillard\",\n",
      "    \"Olivier Lidove\"\n",
      "  ],\n",
      "  \"retrieved_from\": [\n",
      "    \"PubMed\",\n",
      "    \"Semantic Scholar\"\n",
      "  ],\n",
      "  \"category\": \"Publication refering to a registry\",\n",
      "  \"pdf_link\": \"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0233460&type=printable\",\n",
      "  \"population_description\": \"Patients with Fabry disease\",\n",
      "  \"title\": \"Cornea verticillata and acroparesthesia efficiently discriminate clusters of severity in Fabry disease.\",\n",
      "  \"population_size\": 104,\n",
      "  \"mesh_terms\": [\n",
      "    \"Adult\",\n",
      "    \"Cohort Studies\",\n",
      "    \"Cornea\",\n",
      "    \"Fabry Disease\",\n",
      "    \"Female\",\n",
      "    \"France\",\n",
      "    \"Humans\",\n",
      "    \"Middle Aged\",\n",
      "    \"Paresthesia\",\n",
      "    \"Phenotype\",\n",
      "    \"Prospective Studies\",\n",
      "    \"Registries\",\n",
      "    \"Young Adult\"\n",
      "  ],\n",
      "  \"medical_condition\": [\n",
      "    \"Fabry disease\"\n",
      "  ]\n",
      "}\n",
      "{\n",
      "  \"object_id\": \"000088cb-3888-5e61-8097-3ef8aad34609\",\n",
      "  \"outcome_measure\": \"Clinical characteristics and prognosis of postpartum breast cancer (PPBC) based on the diagnosis period of PPBC\",\n",
      "  \"comparator\": \"Not specified\",\n",
      "  \"registry_related\": true,\n",
      "  \"geographical_area\": [\n",
      "    \"South Korea\"\n",
      "  ],\n",
      "  \"intervention\": \"Not specified\",\n",
      "  \"publishing_date\": \"2023-11-01T00:00:00+00:00\",\n",
      "  \"abstract\": \"Postpartum breast cancer (PPBC) is a not well-established subset of breast cancer, and only few studies address its poorer prognosis. However, previous studies show that PPBC is associated with worse outcome with higher rates of metastasis than in young women's breast cancer (YWBC). We aimed to analyze the clinical characteristics and prognosis of PPBC based on the diagnosis period of PPBC. We retrospectively reviewed 208,780 patients with breast cancer from the Korean Breast Cancer Society registry (KBCSR) database between January 2000 and December 2014. We included premenopausal women aged 20-50\\u00a0years who underwent breast cancer surgery. The patients were classified by 5-year intervals according to the diagnosis period of breast cancer, from the first birth to the breast cancer diagnosis. Compared with patients in the other groups, patients diagnosed within postpartum 5\\u00a0years (PPBC\\u2009<\\u20095\\u00a0years) group were younger, had a more advanced stage, had lower estrogen receptor (ER) and progesterone receptor (PR) expression, and had a higher human epidermal growth factor receptor 2 (HER2) positive rate. Further, PPBC\\u2009<\\u20095\\u00a0years group had a worse survival rate than the nulliparous and other groups (5-year cumulative survival: PPBC\\u2009<\\u20095\\u00a0years group, 89%; nulliparous group, 97.3%; 5\\u2009\\u2264\\u2009PPBC\\u2009<\\u200910\\u00a0years group, 93%). In the multivariate analysis, the PPBC\\u2009<\\u20095\\u00a0years group was associated with a worse survival rate (hazard ratio 1.55, 95% confidence interval [CI] 1.148-2.094, p 0.004) after adjustment for age at diagnosis, breast cancer stage, ER and HER2 status, Ki-67 level, and chemotherapy. Our findings indicated that patients diagnosed with breast cancer within the first 5\\u00a0years after delivery had aggressive characteristics and a poor survival rate. It is important to elucidate the pathophysiology of PPBC and establish novel therapeutic strategies to improve the survival rate.\",\n",
      "  \"population_follow_up\": \"Not specified\",\n",
      "  \"design_model_description\": \"Retrospective review of registry data\",\n",
      "  \"data_source_name\": \"Korean Breast Cancer Society registry (KBCSR)\",\n",
      "  \"redirection_link\": \"https://pubmed.ncbi.nlm.nih.gov/37542632\",\n",
      "  \"population_sex\": [\n",
      "    \"Female\"\n",
      "  ],\n",
      "  \"journal\": null,\n",
      "  \"design_model\": \"Cohort studies\",\n",
      "  \"summary\": null,\n",
      "  \"keywords\": [\n",
      "    \"Breast Cancer\",\n",
      "    \"Delivery\",\n",
      "    \"Postpartum\",\n",
      "    \"Prognosis\"\n",
      "  ],\n",
      "  \"chemicals\": [\n",
      "    \"Receptor, ErbB-2\",\n",
      "    \"Receptors, Progesterone\",\n",
      "    \"Receptors, Estrogen\"\n",
      "  ],\n",
      "  \"pmid\": \"37542632\",\n",
      "  \"population_age_group\": [\n",
      "    \"Adult\"\n",
      "  ],\n",
      "  \"retrieved_from\": [\n",
      "    \"PubMed\"\n",
      "  ],\n",
      "  \"authors\": [\n",
      "    \"Pill Sun Paik\",\n",
      "    \"Jung Eun Choi\",\n",
      "    \"Seok Won Lee\",\n",
      "    \"Young Joo Lee\",\n",
      "    \"Young-Joon Kang\",\n",
      "    \"Hyouk Jin Lee\",\n",
      "    \"Soo Youn Bae\"\n",
      "  ],\n",
      "  \"category\": \"Publication refering to a registry\",\n",
      "  \"pdf_link\": null,\n",
      "  \"population_description\": \"Premenopausal women aged 20-50 years who underwent breast cancer surgery\",\n",
      "  \"title\": \"Clinical characteristics and prognosis of postpartum breast cancer.\",\n",
      "  \"population_size\": 208780,\n",
      "  \"mesh_terms\": [\n",
      "    \"Female\",\n",
      "    \"Humans\",\n",
      "    \"Breast Neoplasms\",\n",
      "    \"Retrospective Studies\",\n",
      "    \"Prognosis\",\n",
      "    \"Breast\",\n",
      "    \"Receptor, ErbB 2\",\n",
      "    \"Postpartum Period\",\n",
      "    \"Receptors, Progesterone\",\n",
      "    \"Receptors, Estrogen\"\n",
      "  ],\n",
      "  \"medical_condition\": [\n",
      "    \"Postpartum breast cancer\",\n",
      "    \"breast cancer\"\n",
      "  ]\n",
      "}\n",
      "{\n",
      "  \"object_id\": \"00008b13-daf4-59f2-a238-f7860107cafb\",\n",
      "  \"outcome_measure\": null,\n",
      "  \"comparator\": null,\n",
      "  \"registry_related\": true,\n",
      "  \"geographical_area\": null,\n",
      "  \"intervention\": null,\n",
      "  \"publishing_date\": \"2008-11-01T00:00:00+00:00\",\n",
      "  \"abstract\": \"At some institutions, catheter angiography is used for confirmation of aortic injuries and equivocal MDCT findings. Because of the speed and efficiency of 64-MDCT, we believe that diagnostic catheter angiography may be obsolete. The purpose of this study was to review our experience with 64-MDCT in the evaluation of acute traumatic aortic injury (ATAI). The trauma registry at a level 1 trauma center was reviewed to find cases of ATAI occurring between March 1, 2005, and July 31, 2007. MDCT images were correlated with transcatheter angiograms when obtained. Surgical and clinical reports were reviewed to confirm abnormal and normal findings and the stability of the conditions of patients undergoing conservative treatment. After level 1 or level 2 trauma, 1,344 patients underwent contrast-enhanced 64-MDCT. Twenty-four patients (1.79%) were found to have 25 aortic injuries. All patients had direct MDCT signs of ATAI. Ten catheter angiograms were obtained after MDCT. The presence of direct signs was confirmed in three cases. In five cases, indirect signs were found to be normal findings. In two cases, the findings remained equivocal after MDCT and conventional angiography. Fourteen patients underwent surgical repair of the aorta, six underwent conservative management, and four patients died of other injuries. No patient with equivocal or indirect findings needed surgical repair. The sensitivity of 64-MDCT was 96.0%; specificity, 99.8%; positive predictive value, 92.3%; negative predictive value, 99.9%; and accuracy, 99.8%. Direct signs of ATAI on contrast-enhanced 64-MDCT scans do not have to be confirmed with catheter angiography. In our population, diagnostic transcatheter angiography was of limited value for clarifying equivocal or indirect MDCT findings.\",\n",
      "  \"population_follow_up\": null,\n",
      "  \"design_model_description\": null,\n",
      "  \"data_source_name\": \"\",\n",
      "  \"redirection_link\": \"https://pubmed.ncbi.nlm.nih.gov/18941102\",\n",
      "  \"population_sex\": null,\n",
      "  \"journal\": \"AJR. American journal of roentgenology\",\n",
      "  \"design_model\": null,\n",
      "  \"summary\": \"Direct signs of ATAI on contrast-enhanced 64-MDCT scans do not have to be confirmed with catheter angiography, and diagnostic transcatheterAngiography was of limited value for clarifying equivocal or indirect MDCT findings.\",\n",
      "  \"keywords\": [],\n",
      "  \"chemicals\": [],\n",
      "  \"population_age_group\": null,\n",
      "  \"pmid\": \"18941102\",\n",
      "  \"retrieved_from\": [\n",
      "    \"Semantic Scholar\",\n",
      "    \"PubMed\"\n",
      "  ],\n",
      "  \"authors\": [\n",
      "    \"Scott D Steenburg\",\n",
      "    \"James G Ravenel\"\n",
      "  ],\n",
      "  \"category\": \"Publication refering to a registry\",\n",
      "  \"medical_condition\": null,\n",
      "  \"population_description\": null,\n",
      "  \"pdf_link\": null,\n",
      "  \"population_size\": null,\n",
      "  \"mesh_terms\": [\n",
      "    \"Acute Disease\",\n",
      "    \"Adolescent\",\n",
      "    \"Adult\",\n",
      "    \"Aged\",\n",
      "    \"Aorta, Thoracic\",\n",
      "    \"Coronary Angiography\",\n",
      "    \"Female\",\n",
      "    \"Heart Injuries\",\n",
      "    \"Humans\",\n",
      "    \"Male\",\n",
      "    \"Middle Aged\",\n",
      "    \"Reproducibility Of Results\",\n",
      "    \"Sensitivity And Specificity\",\n",
      "    \"Thoracic Injuries\"\n",
      "  ],\n",
      "  \"title\": \"Acute traumatic thoracic aortic injuries: experience with 64-MDCT.\"\n",
      "}\n",
      "{\n",
      "  \"object_id\": \"0000f5dd-506e-5949-b64e-bbff8030c667\",\n",
      "  \"outcome_measure\": \"Use of public, occupational and private outpatient primary health care\",\n",
      "  \"comparator\": \"Not specified\",\n",
      "  \"registry_related\": true,\n",
      "  \"geographical_area\": [\n",
      "    \"City of Oulu\",\n",
      "    \"Finland\"\n",
      "  ],\n",
      "  \"intervention\": \"Not specified\",\n",
      "  \"publishing_date\": \"2020-01-01T00:00:00+00:00\",\n",
      "  \"abstract\": \"There is little knowledge on socioeconomic differences in use of health care organized by different care schemes and on exclusive and concurrent use of health care at different schemes in different socioeconomic groups. In Finland, public, occupational and private schemes offer parallel outpatient primary health care services. Each scheme mainly reaches different population groups because of differences in availability, costs and gatekeeping. This study aimed to analyse how the probability of using health care organized by the three schemes differed by socioeconomic status in a working-age population. Individual-level register-based data on use of public, occupational and private outpatient primary health care during 2013 as well as data on sociodemographic covariates were linked for the total population aged 25-64 of the city of Oulu, Finland. Data were analysed with descriptive methods and multinomial logistic regression models. Those in the study population most often used only occupational care or only public care, or did not use any of the studied health care schemes at all. The lower the socioeconomic status, the higher was the probability of not using care or using only public care. The higher the socioeconomic status, the higher was the probability of using occupational care-either only occupational care or occupational care in combination with private care. Education, occupational class and income were all associated with care use also when adjusted for sociodemographic covariates and chronic disease, but income proved to be the strongest predictor of the three. The results reflect the design of the Finnish health care system, with a strong occupational health care scheme for the employed population contributing to inequality in use of health care and potentially to health inequality between socioeconomic groups.\",\n",
      "  \"population_follow_up\": \"2013 (specific duration not provided)\",\n",
      "  \"design_model_description\": \"Register-linkage study\",\n",
      "  \"data_source_name\": \"Finnish Health Care Register\",\n",
      "  \"journal\": null,\n",
      "  \"population_sex\": [\n",
      "    \"Not specified\"\n",
      "  ],\n",
      "  \"redirection_link\": \"https://pubmed.ncbi.nlm.nih.gov/32298356\",\n",
      "  \"design_model\": \"Not specified\",\n",
      "  \"summary\": null,\n",
      "  \"keywords\": [],\n",
      "  \"chemicals\": [],\n",
      "  \"pmid\": \"32298356\",\n",
      "  \"population_age_group\": [\n",
      "    \"Not specified\"\n",
      "  ],\n",
      "  \"authors\": [\n",
      "    \"Jenni Blomgren\",\n",
      "    \"Lauri J Virta\"\n",
      "  ],\n",
      "  \"retrieved_from\": [\n",
      "    \"PubMed\"\n",
      "  ],\n",
      "  \"category\": \"Publication refering to a registry\",\n",
      "  \"medical_condition\": [\n",
      "    \"Not specified\"\n",
      "  ],\n",
      "  \"population_description\": \"Working-age population in Finland\",\n",
      "  \"title\": \"Socioeconomic differences in use of public, occupational and private health care: A register-linkage study of a working-age population in Finland.\",\n",
      "  \"population_size\": 25,\n",
      "  \"mesh_terms\": [\n",
      "    \"Adult\",\n",
      "    \"Ambulatory Care\",\n",
      "    \"Employment\",\n",
      "    \"Female\",\n",
      "    \"Finland\",\n",
      "    \"Health Status Disparities\",\n",
      "    \"Humans\",\n",
      "    \"Income\",\n",
      "    \"Logistic Models\",\n",
      "    \"Male\",\n",
      "    \"Middle Aged\",\n",
      "    \"Occupational Health Services\",\n",
      "    \"Primary Health Care\",\n",
      "    \"Private Sector\",\n",
      "    \"Public Sector\",\n",
      "    \"Registries\",\n",
      "    \"Social Class\",\n",
      "    \"Socioeconomic Factors\"\n",
      "  ],\n",
      "  \"pdf_link\": null\n",
      "}\n",
      "{\n",
      "  \"object_id\": \"00011633-caf4-5831-9f85-0b2286a8ba43\",\n",
      "  \"outcome_measure\": \"Myositis-specific antibodies and clinical characteristics\",\n",
      "  \"comparator\": \"Not specified\",\n",
      "  \"registry_related\": true,\n",
      "  \"geographical_area\": [\n",
      "    \"Argentina\"\n",
      "  ],\n",
      "  \"intervention\": \"Not specified\",\n",
      "  \"publishing_date\": \"2022-05-10T00:00:00+00:00\",\n",
      "  \"abstract\": \"References 1 Gambichler T, Boms S, Susok L et al. Cutaneous findings following COVID-19 vaccination: review of world literature and own experience. J Eur Acad Dermatol Venereol 2022; 36: 172\\u2013180. 2 Connolly CM, Ruddy JA, Boyarsky BJ et al. Disease flare and reactogenicity in patients with rheumatic and musculoskeletal diseases following twodose SARS-CoV-2 messenger RNA vaccination. Arthritis Rheumatol 2022; 74: 28\\u201332. 3 Udkoff J, Cohen PR. Amyopathic dermatomyositis: a concise review of clinical manifestations and associated malignancies. Am J Clin Dermatol 2016; 17: 509\\u2013518. 4 G omez GN, P erez N, Poccard AB et al. Myositis-specific antibodies and clinical characteristics in patients with autoimmune inflammatory myopathies: reported by the argentine registry of inflammatory myopathies of the argentine Society of Rheumatology. Clin Rheumatol 2021; 40: 4473\\u20134483. 5 Kreuter A, Licciardi-Fernandez MJ, Burmann SN et al. Induction and exacerbation of subacute cutaneous lupus erythematosus following mRNA-based or adenoviral vector-based SARS-CoV-2 vaccination. Clin Exp Dermatol 2022; 47: 161\\u2013163. 6 Gouda W, Albasri A, Alsaqabi F, Al Sabah HY, Alkandari M, Abdelnaby H. Dermatomyositis following BNT162b2 mRNA COVID-19 vaccination. J Korean Med Sci 2022; 37: e32. 7 Wu M, Karim M, Ashinoff R. COVID-19 vaccine associated dermatomyositis. JAAD Case Rep 2022; 23: 58\\u201360. 8 Yoshida A, Ikegami T, Igawa K. Two cases of anti-TIF1-c antibody positive dermatomyositis with manifested symptoms after SARS-CoV-19 vaccination. J Eur Acad Dermatol Venereol 2022, Online ahead of print. 9 Lee AYS, Lee C, Brown DA, Suan D. Development of anti-NXP2 dermatomyositis following Comirnaty COVID-19 vaccination. Postgrad Med J. 2022, Online ahead of print.\",\n",
      "  \"data_source_name\": \"Argentine Registry of Inflammatory Myopathies of the Argentine Society of Rheumatology\",\n",
      "  \"design_model_description\": \"Observational studies\",\n",
      "  \"population_follow_up\": \"Not specified\",\n",
      "  \"redirection_link\": \"https://www.semanticscholar.org/paper/e54ff730657d6cceac24345ab316c19d2666769e\",\n",
      "  \"population_sex\": [\n",
      "    \"Not specified\"\n",
      "  ],\n",
      "  \"journal\": \"Journal of the European Academy of Dermatology and Venereology\",\n",
      "  \"design_model\": \"Cohort studies\",\n",
      "  \"summary\": \"A review of clinical manifestations and associated malignancies in patients with rheumatic and musculoskeletal diseases following twodose SARS-CoV-2 messenger RNA vaccination and the development of anti-NXP2 dermatomyositis following Comirnaty COVID-19 vaccination shows clear trends in autoimmune inflammatory myopathies.\",\n",
      "  \"keywords\": null,\n",
      "  \"chemicals\": null,\n",
      "  \"population_age_group\": [\n",
      "    \"Not specified\"\n",
      "  ],\n",
      "  \"pmid\": \"35536566\",\n",
      "  \"retrieved_from\": [\n",
      "    \"Semantic Scholar\"\n",
      "  ],\n",
      "  \"authors\": [\n",
      "    \"N. Kluger\"\n",
      "  ],\n",
      "  \"category\": \"Publication refering to a registry\",\n",
      "  \"pdf_link\": null,\n",
      "  \"title\": \"Allergic reaction to red cosmetic lip tattoo with possible exacerbations after SARS\\u2010CoV\\u20102 vaccination\",\n",
      "  \"population_description\": \"Patients with autoimmune inflammatory myopathies\",\n",
      "  \"population_size\": null,\n",
      "  \"mesh_terms\": null,\n",
      "  \"medical_condition\": [\n",
      "    \"Autoimmune inflammatory myopathies\"\n",
      "  ]\n",
      "}\n",
      "{\n",
      "  \"object_id\": \"000168f2-596b-5cef-8c17-fbf40d8c4312\",\n",
      "  \"outcome_measure\": \"Composite major adverse cardiac and cerebrovascular events (MACCE), angiographic late luminal loss, stent volume obstruction by intravascular ultrasound analysis\",\n",
      "  \"comparator\": \"Not specified\",\n",
      "  \"registry_related\": true,\n",
      "  \"geographical_area\": [\n",
      "    \"Not specified\"\n",
      "  ],\n",
      "  \"intervention\": \"Endothelial progenitor cell (EPC) capture stents\",\n",
      "  \"publishing_date\": \"2005-05-17T00:00:00+00:00\",\n",
      "  \"abstract\": \"This study was designed to evaluate whether rapid endothelialization of stainless steel stents with a functional endothelium prevents stent thrombosis and reduces the restenotic process. A \\\"pro-healing\\\" approach for prevention of post-stenting restenosis is theoretically favored over the use of cytotoxic or cytostatic local pharmacologic therapies. It is believed that the central role of the vascular endothelium is to maintain quiescence of the underlying media and adventitia. Sixteen patients with de novo coronary artery disease were successfully treated with implantation of endothelial progenitor cell (EPC) capture stents. Complete procedural and angiographic success was achieved in all 16 patients. The nine-month composite major adverse cardiac and cerebrovascular events (MACCE) rate was 6.3% as a result of a symptom-driven target vessel revascularization in a single patient. There were no other MACCE despite only one month of clopidogrel treatment. At six-month follow-up, mean angiographic late luminal loss was 0.63 +/- 0.52 mm, and percent stent volume obstruction by intravascular ultrasound analysis was 27.2 +/- 20.9%. This first human clinical investigation of this technology demonstrates that the EPC capture coronary stent is safe and feasible for the treatment of de novo coronary artery disease. Further developments in this technology are warranted to evaluate the efficacy of this device for the treatment of coronary artery disease.\",\n",
      "  \"population_follow_up\": \"Six months\",\n",
      "  \"design_model_description\": \"First in man study\",\n",
      "  \"data_source_name\": \"HEALING-FIM Registry\",\n",
      "  \"redirection_link\": \"https://pubmed.ncbi.nlm.nih.gov/15893169\",\n",
      "  \"population_sex\": [\n",
      "    \"Not specified\"\n",
      "  ],\n",
      "  \"journal\": \"Journal of the American College of Cardiology\",\n",
      "  \"design_model\": \"Randomized Control Trial (RCT)\",\n",
      "  \"summary\": \"This first human clinical investigation of this technology demonstrates that the EPC capture coronary stent is safe and feasible for the treatment of de novo coronary artery disease.\",\n",
      "  \"keywords\": [],\n",
      "  \"chemicals\": [\n",
      "    \"Antibodies, Monoclonal\",\n",
      "    \"Antigens, CD34\",\n",
      "    \"Coated Materials, Biocompatible\"\n",
      "  ],\n",
      "  \"population_age_group\": [\n",
      "    \"Not specified\"\n",
      "  ],\n",
      "  \"pmid\": \"15893169\",\n",
      "  \"authors\": [\n",
      "    \"Jiro Aoki\",\n",
      "    \"Patrick W Serruys\",\n",
      "    \"Heleen van Beusekom\",\n",
      "    \"Andrew T L Ong\",\n",
      "    \"Eugene P McFadden\",\n",
      "    \"Georgios Sianos\",\n",
      "    \"Willem J van der Giessen\",\n",
      "    \"Evelyn Regar\",\n",
      "    \"Pim J de Feyter\",\n",
      "    \"H Richard Davis\",\n",
      "    \"Stephen Rowland\",\n",
      "    \"Michael J B Kutryk\"\n",
      "  ],\n",
      "  \"retrieved_from\": [\n",
      "    \"Semantic Scholar\",\n",
      "    \"PubMed\"\n",
      "  ],\n",
      "  \"category\": \"Publication refering to a registry\",\n",
      "  \"pdf_link\": null,\n",
      "  \"title\": \"Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry.\",\n",
      "  \"medical_condition\": [\n",
      "    \"Coronary artery disease\"\n",
      "  ],\n",
      "  \"population_size\": 16,\n",
      "  \"mesh_terms\": [\n",
      "    \"Aged\",\n",
      "    \"Angina Pectoris\",\n",
      "    \"Antibodies, Monoclonal\",\n",
      "    \"Antigens, CD34\",\n",
      "    \"Coated Materials, Biocompatible\",\n",
      "    \"Coronary Angiography\",\n",
      "    \"Coronary Stenosis\",\n",
      "    \"Endosonography\",\n",
      "    \"Endothelial Cells\",\n",
      "    \"Feasibility Studies\",\n",
      "    \"Female\",\n",
      "    \"Fibromuscular Dysplasia\",\n",
      "    \"Humans\",\n",
      "    \"Immunomagnetic Separation\",\n",
      "    \"Male\",\n",
      "    \"Mesenchymal Stem Cells\",\n",
      "    \"Middle Aged\",\n",
      "    \"Prospective Studies\",\n",
      "    \"Prosthesis Failure\",\n",
      "    \"Registries\",\n",
      "    \"Stents\",\n",
      "    \"Treatment Outcome\"\n",
      "  ],\n",
      "  \"population_description\": \"Patients with de novo coronary artery disease\"\n",
      "}\n",
      "{\n",
      "  \"object_id\": \"0002004d-00b2-52d6-bb7d-ba344e8ab8ec\",\n",
      "  \"outcome_measure\": \"Survival\",\n",
      "  \"comparator\": \"Patients who received definitive local therapy versus those who did not\",\n",
      "  \"registry_related\": true,\n",
      "  \"geographical_area\": [\n",
      "    \"Not specified\"\n",
      "  ],\n",
      "  \"intervention\": \"Definitive local therapy of primary disease - chest radiotherapy >/= 45 Gy (ChRT) or thoracic resection (TS) of their primary tumor and locoregional lymph nodes\",\n",
      "  \"publishing_date\": \"2008-05-20T00:00:00+00:00\",\n",
      "  \"abstract\": \"19020 Background: Standard therapy for non-small cell lung cancer (NSCLC) brain metastases is radiotherapy and/or surgical resection for all visible lesions. This practice has been able to palliate brain metastasis-related symptoms and to improve survival. Similarly, we hypothesize that local therapy for other sites of disease, particularly the primary tumor and locoregional lymph node metastases, may further improve survival. Methods: Patients with NSCLC metastatic to one organ site were identified in the M.D. Anderson Cancer Center Tumor Registry, Thoracic Radiation Oncology, and Neurosurgery databases, and survival was compared for patients who received definitive local therapy of primary disease - chest radiotherapy >/= 45 Gy (ChRT) or thoracic resection (TS) of their primary tumor and locoregional lymph nodes - versus those who did not. Results: 120 patients had brain as a solitary organ site of metastasis, and 115 (96%) received brain metastasis treatment with surgical resection, stereotactic radios...\",\n",
      "  \"data_source_name\": \"M.D. Anderson Cancer Center Tumor Registry, Thoracic Radiation Oncology, and Neurosurgery databases\",\n",
      "  \"design_model_description\": \"Retrospective cohort study\",\n",
      "  \"population_follow_up\": \"Not specified\",\n",
      "  \"journal\": null,\n",
      "  \"population_sex\": [\n",
      "    \"Not specified\"\n",
      "  ],\n",
      "  \"redirection_link\": \"https://www.semanticscholar.org/paper/827cb7d457586a3a3404f035c57182ab3923dc33\",\n",
      "  \"design_model\": \"Cohort studies\",\n",
      "  \"summary\": \"It is hypothesize that local therapy for other sites of disease, particularly the primary tumor and locoregional lymph node metastases, may further improve survival.\",\n",
      "  \"keywords\": null,\n",
      "  \"chemicals\": null,\n",
      "  \"pmid\": null,\n",
      "  \"population_age_group\": [\n",
      "    \"Not specified\"\n",
      "  ],\n",
      "  \"authors\": [\n",
      "    \"J. Lee\",\n",
      "    \"Sarah H. Taylor\",\n",
      "    \"B. Bekele\",\n",
      "    \"M. Debnam\",\n",
      "    \"E. Chang\",\n",
      "    \"P. Allen\",\n",
      "    \"D. Suki\",\n",
      "    \"D. Karp\",\n",
      "    \"D. Stewart\",\n",
      "    \"Y. Oh\"\n",
      "  ],\n",
      "  \"retrieved_from\": [\n",
      "    \"Semantic Scholar\"\n",
      "  ],\n",
      "  \"category\": \"Publication refering to a registry\",\n",
      "  \"medical_condition\": [\n",
      "    \"Non-small cell lung cancer (NSCLC)\",\n",
      "    \"brain metastasis\"\n",
      "  ],\n",
      "  \"title\": \"Local therapy of primary disease and survival in non-small cell lung cancer metastatic to brain and other single organ sites\",\n",
      "  \"population_description\": \"Patients with non-small cell lung cancer (NSCLC) metastatic to one organ site\",\n",
      "  \"population_size\": 120,\n",
      "  \"mesh_terms\": null,\n",
      "  \"pdf_link\": null\n",
      "}\n",
      "{\n",
      "  \"object_id\": \"00020b5d-4fb1-5d6d-9480-439522c03c92\",\n",
      "  \"outcome_measure\": \"Receiving lobectomy (or bilobectomy) treatment\",\n",
      "  \"comparator\": \"Not specified\",\n",
      "  \"registry_related\": true,\n",
      "  \"geographical_area\": [\n",
      "    \"California\",\n",
      "    \"USA\"\n",
      "  ],\n",
      "  \"intervention\": \"Not specified\",\n",
      "  \"publishing_date\": \"2013-04-01T00:00:00+00:00\",\n",
      "  \"abstract\": \"Social disparities permeate non-small cell lung cancer (NSCLC) treatment, yet little is known about the effect of insurance status on the delivery of guideline surgical treatment for early-stage (I or II) NSCLC. We used the California Cancer Registry (1996 through 2008) to identify patients 50 to 94 years old with early-stage NSCLC. We used logistic regression models to assess whether or not insurance status (private insurance, Medicare, Medicaid, no insurance, and unknown) had an effect on whether or not a lobectomy (or bilobectomy) is performed. A total of 10,854 patients met our inclusion criteria. Compared with patients with private insurance, we found that patients with Medicare (adjusted odds ratio [aOR] 0.87; 95% confidence interval [CI]: 0.79 to 0.95), Medicaid (aOR 0.45; 95% CI: 0.36 to 0.57), or no insurance (aOR 0.45; 95% CI: 0.29 to 0.70) were significantly less likely to undergo lobectomy, even after adjusting for patient factors (age, race, and gender) and tumor characteristics (histology and tumor size). Increasing age, African American race, squamous cell carcinoma, and increasing tumor size were significant independent negative predictors of whether or not a lobectomy was performed. Patients without private insurance were significantly less likely than patients with private insurance to undergo a lobectomy for early-stage NSCLC. The variables(s) contributing to this disparity have yet to be elucidated.\",\n",
      "  \"population_follow_up\": \"Not specified\",\n",
      "  \"design_model_description\": \"Retrospective cohort study\",\n",
      "  \"data_source_name\": \"California Cancer Registry\",\n",
      "  \"redirection_link\": \"https://pubmed.ncbi.nlm.nih.gov/23415239\",\n",
      "  \"population_sex\": [\n",
      "    \"Male\",\n",
      "    \"Female\"\n",
      "  ],\n",
      "  \"journal\": null,\n",
      "  \"design_model\": \"Cohort studies\",\n",
      "  \"summary\": null,\n",
      "  \"keywords\": [],\n",
      "  \"chemicals\": [],\n",
      "  \"population_age_group\": [\n",
      "    \"Adult\"\n",
      "  ],\n",
      "  \"pmid\": \"23415239\",\n",
      "  \"retrieved_from\": [\n",
      "    \"PubMed\"\n",
      "  ],\n",
      "  \"authors\": [\n",
      "    \"Shawn S Groth\",\n",
      "    \"Waddah B Al-Refaie\",\n",
      "    \"Wei Zhong\",\n",
      "    \"Selwyn M Vickers\",\n",
      "    \"Michael A Maddaus\",\n",
      "    \"Jonathan D'Cunha\",\n",
      "    \"Elizabeth B Habermann\"\n",
      "  ],\n",
      "  \"category\": \"Publication refering to a registry\",\n",
      "  \"pdf_link\": null,\n",
      "  \"title\": \"Effect of insurance status on the surgical treatment of early-stage non-small cell lung cancer.\",\n",
      "  \"medical_condition\": [\n",
      "    \"Non-small cell lung cancer\",\n",
      "    \"stage I or II\"\n",
      "  ],\n",
      "  \"population_size\": 10854,\n",
      "  \"mesh_terms\": [\n",
      "    \"Aged\",\n",
      "    \"Aged, 80 And Over\",\n",
      "    \"Carcinoma, Non Small Cell Lung\",\n",
      "    \"Confidence Intervals\",\n",
      "    \"Female\",\n",
      "    \"Humans\",\n",
      "    \"Insurance Coverage\",\n",
      "    \"Insurance, Health\",\n",
      "    \"Lung Neoplasms\",\n",
      "    \"Male\",\n",
      "    \"Medicaid\",\n",
      "    \"Medicare\",\n",
      "    \"Middle Aged\",\n",
      "    \"Neoplasm Staging\",\n",
      "    \"Odds Ratio\",\n",
      "    \"Pneumonectomy\",\n",
      "    \"Survival Rate\",\n",
      "    \"United States\"\n",
      "  ],\n",
      "  \"population_description\": \"Patients 50 to 94 years old with early-stage (I or II) non-small cell lung cancer (NSCLC)\"\n",
      "}\n",
      "{\n",
      "  \"object_id\": \"000226dd-9d13-5ae1-b161-a439204d26ae\",\n",
      "  \"outcome_measure\": \"Identification of pathogenic or likely pathogenic variants in genes associated with hereditary pancreatic cancer predisposition\",\n",
      "  \"comparator\": \"Not specified\",\n",
      "  \"registry_related\": true,\n",
      "  \"geographical_area\": [\n",
      "    \"Not specified\"\n",
      "  ],\n",
      "  \"intervention\": \"Not specified\",\n",
      "  \"publishing_date\": \"2018-04-01T00:00:00+00:00\",\n",
      "  \"abstract\": \"Approximately 5-10% of all pancreatic cancer patients carry a predisposing mutation in a known susceptibility gene. Since >90% of patients present with late stage disease, it is crucial to identify high risk individuals who may be amenable to early detection or other prevention. To explore the spectrum of hereditary pancreatic cancer susceptibility, we evaluated germline DNA from pancreatic cancer participants (n\\u2009=\\u200953) from a large hereditary cancer registry. For those without a known predisposition mutation gene (n\\u2009=\\u200949), germline next generation sequencing was completed using targeted capture for 706 candidate genes. We identified 16 of 53 participants (30%) with a pathogenic (P) or likely pathogenic (LP) variant that may be related to their hereditary pancreatic cancer predisposition; seven had mutations in genes associated with well-known cancer syndromes (13%) [ATM (2), BRCA2 (3), MSH2 (1), MSH6 (1)]. Many had mutations in Fanconi anemia complex genes [BRCA2 (3 participants), FANCF, FANCM]. Eight participants had rare protein truncating variants of uncertain significance with no other P or LP variants. Earlier age of pancreatic cancer diagnosis (57.5 vs 64.8\\u00a0years) was indicative of possessing a P or LP variant, as was cancer family history (p values <0.0001). Our multigene panel approach for identifying known cancer predisposing genetic susceptibility in those at risk for hereditary pancreatic cancer may have direct applicability to clinical practice in cases with mutations in actionable genes. Future pancreatic cancer predisposition studies should include evaluation of the Fanconi anemia genes.\",\n",
      "  \"population_follow_up\": \"Not specified\",\n",
      "  \"design_model_description\": \"Observational studies\",\n",
      "  \"data_source_name\": \"A large hereditary cancer registry\",\n",
      "  \"journal\": \"Familial Cancer\",\n",
      "  \"population_sex\": [\n",
      "    \"Not specified\"\n",
      "  ],\n",
      "  \"redirection_link\": \"https://pubmed.ncbi.nlm.nih.gov/28687971\",\n",
      "  \"design_model\": \"Cohort studies\",\n",
      "  \"summary\": \"The authors' multigene panel approach for identifying known cancer predisposing genetic susceptibility in those at risk for hereditary pancreatic cancer may have direct applicability to clinical practice in cases with mutations in actionable genes.\",\n",
      "  \"keywords\": [\n",
      "    \"BRCA2\",\n",
      "    \"Germline\",\n",
      "    \"Hereditary\",\n",
      "    \"Pancreatic Cancer\",\n",
      "    \"Susceptibility\"\n",
      "  ],\n",
      "  \"chemicals\": [\n",
      "    \"BRCA2 Protein\",\n",
      "    \"BRCA2 protein, human\",\n",
      "    \"Biomarkers, Tumor\",\n",
      "    \"FANCF protein, human\",\n",
      "    \"Fanconi Anemia Complementation Group F Protein\",\n",
      "    \"FANCM protein, human\",\n",
      "    \"DNA Helicases\"\n",
      "  ],\n",
      "  \"pmid\": \"28687971\",\n",
      "  \"population_age_group\": [\n",
      "    \"Not specified\"\n",
      "  ],\n",
      "  \"authors\": [\n",
      "    \"Thomas P Slavin\",\n",
      "    \"Susan L Neuhausen\",\n",
      "    \"Bita Nehoray\",\n",
      "    \"Mariana Niell-Swiller\",\n",
      "    \"Ilana Solomon\",\n",
      "    \"Christina Rybak\",\n",
      "    \"Kathleen Blazer\",\n",
      "    \"Aaron Adamson\",\n",
      "    \"Kai Yang\",\n",
      "    \"Sharon Sand\",\n",
      "    \"Nancy Guerrero-Llamas\",\n",
      "    \"Danielle Castillo\",\n",
      "    \"Josef Herzog\",\n",
      "    \"Xiwei Wu\",\n",
      "    \"Shu Tao\",\n",
      "    \"Shivali Raja\",\n",
      "    \"Vincent Chung\",\n",
      "    \"Gagandeep Singh\",\n",
      "    \"Sue Nadesan\",\n",
      "    \"Sandra Brown\",\n",
      "    \"Marcia Cruz-Correa\",\n",
      "    \"Gloria M Petersen\",\n",
      "    \"Jeffrey Weitzel\"\n",
      "  ],\n",
      "  \"retrieved_from\": [\n",
      "    \"Semantic Scholar\",\n",
      "    \"PubMed\"\n",
      "  ],\n",
      "  \"category\": \"Publication refering to a registry\",\n",
      "  \"pdf_link\": \"https://europepmc.org/articles/pmc5758436?pdf=render\",\n",
      "  \"title\": \"The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes.\",\n",
      "  \"medical_condition\": [\n",
      "    \"Pancreatic cancer\"\n",
      "  ],\n",
      "  \"population_size\": 53,\n",
      "  \"mesh_terms\": [\n",
      "    \"Adult\",\n",
      "    \"Aged\",\n",
      "    \"Aged, 80 And Over\",\n",
      "    \"BRCA2 Protein\",\n",
      "    \"Biomarkers, Tumor\",\n",
      "    \"Carcinoma, Pancreatic Ductal\",\n",
      "    \"DNA Helicases\",\n",
      "    \"DNA Mutational Analysis\",\n",
      "    \"Fanconi Anemia\",\n",
      "    \"Fanconi Anemia Complementation Group F Protein\",\n",
      "    \"Female\",\n",
      "    \"Genetic Predisposition To Disease\",\n",
      "    \"Genetic Testing\",\n",
      "    \"Germ Line Mutation\",\n",
      "    \"High Throughput Nucleotide Sequencing\",\n",
      "    \"Humans\",\n",
      "    \"Male\",\n",
      "    \"Middle Aged\",\n",
      "    \"Mutation\",\n",
      "    \"Neoplastic Syndromes, Hereditary\",\n",
      "    \"Pancreatic Neoplasms\",\n",
      "    \"Registries\",\n",
      "    \"Young Adult\"\n",
      "  ],\n",
      "  \"population_description\": \"Pancreatic cancer patients\"\n",
      "}\n",
      "{\n",
      "  \"object_id\": \"000285c1-3973-52a8-824b-744d6feee852\",\n",
      "  \"outcome_measure\": \"Difficulty of operation (easy, difficult, very difficult, or converted to open cholecystectomy)\",\n",
      "  \"comparator\": \"Not specified\",\n",
      "  \"registry_related\": true,\n",
      "  \"geographical_area\": [\n",
      "    \"Thailand\"\n",
      "  ],\n",
      "  \"intervention\": \"Not specified\",\n",
      "  \"publishing_date\": \"2023-03-01T00:00:00+00:00\",\n",
      "  \"abstract\": \"Background: Laparoscopic cholecystectomy (LC) is one of the most common abdominal operations. The difficult cases are still challenging for surgeons. There had been many studies providing several preoperative models to predict difficult LC or conversion. Randhawa's scoring system was a simple and practical predictive model for clinicians. The modification was reported to be more preferable for delayed LC. This study aimed to confirm the advantage of modified predictive model in larger sample size. Materials and Methods: This retrospective cohort study reviewed medical records of patients who underwent LC since January 2017 to December 2021. The difficulty of operation was categorized into three groups: easy, difficult, and very difficult. Multivariate analysis was performed to define significant factors of very difficult and converted cases. The predictive scores were calculated by using the original Randhawa's model and the modification, then compared with actual outcome. Results: There were 567 cases of delayed LC in this study, with 44 cases (7.8%) converted to open cholecystectomy. Four factors (previous cholecystitis, previous endoscopic retrograde cholangiopancreatography, higher ALP, and gallbladder wall thickening) for very difficult group and five factors (previous cholecystitis, previous cholangitis, higher white blood cell count, gallbladder wall thickening, and contracted gallbladder) for conversion were significant. The modification provided the better correlation and higher area of receiver operating characteristic (ROC) curve comparing with the original model. Conclusion: The modification of Randhawa's model was supposed to be more preferable for predicting the difficulty in elective LC. Thai Clinical Trials Registry No. 20220712006.\",\n",
      "  \"data_source_name\": \"Thai Clinical Trials Registry\",\n",
      "  \"design_model_description\": \"Retrospective cohort study\",\n",
      "  \"population_follow_up\": \"Not specified\",\n",
      "  \"redirection_link\": \"https://pubmed.ncbi.nlm.nih.gov/36445743\",\n",
      "  \"population_sex\": [\n",
      "    \"Not specified\"\n",
      "  ],\n",
      "  \"journal\": \"Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A\",\n",
      "  \"design_model\": \"Cohort studies\",\n",
      "  \"summary\": \"The modification of Randhawa's model was supposed to be more preferable for predicting the difficulty in elective LC and provided the better correlation and higher area of receiver operating characteristic (ROC) curve comparing with the original model.\",\n",
      "  \"keywords\": [\n",
      "    \"Conversion\",\n",
      "    \"Laparoscopic Cholecystectomy\",\n",
      "    \"Open Cholecystectomy\",\n",
      "    \"Prediction\",\n",
      "    \"Scoring System\"\n",
      "  ],\n",
      "  \"chemicals\": [],\n",
      "  \"population_age_group\": [\n",
      "    \"Not specified\"\n",
      "  ],\n",
      "  \"pmid\": \"36445743\",\n",
      "  \"authors\": [\n",
      "    \"Assanee Tongyoo\",\n",
      "    \"Aekkaphod Liwattanakun\",\n",
      "    \"Ekkapak Sriussadaporn\",\n",
      "    \"Palin Limpavitayaporn\",\n",
      "    \"Chatchai Mingmalairak\"\n",
      "  ],\n",
      "  \"retrieved_from\": [\n",
      "    \"PubMed\",\n",
      "    \"Semantic Scholar\"\n",
      "  ],\n",
      "  \"category\": \"Publication refering to a registry\",\n",
      "  \"medical_condition\": [\n",
      "    \"Gallstones\",\n",
      "    \"cholecystitis\"\n",
      "  ],\n",
      "  \"population_description\": \"Patients who underwent laparoscopic cholecystectomy (LC)\",\n",
      "  \"pdf_link\": null,\n",
      "  \"population_size\": 567,\n",
      "  \"mesh_terms\": [\n",
      "    \"Humans\",\n",
      "    \"Cholecystectomy, Laparoscopic\",\n",
      "    \"Retrospective Studies\",\n",
      "    \"Cholecystectomy\",\n",
      "    \"Cholecystitis\"\n",
      "  ],\n",
      "  \"title\": \"The Modification of a Preoperative Scoring System to Predict Difficult Elective Laparoscopic Cholecystectomy.\"\n",
      "}\n",
      "{\n",
      "  \"object_id\": \"000295f9-c288-59c0-84a0-37f19af4f42a\",\n",
      "  \"outcome_measure\": \"Thromboembolic events (TE) and death\",\n",
      "  \"comparator\": \"Not specified\",\n",
      "  \"registry_related\": true,\n",
      "  \"geographical_area\": [\n",
      "    \"Japan\"\n",
      "  ],\n",
      "  \"intervention\": \"Not specified\",\n",
      "  \"publishing_date\": \"2018-04-25T00:00:00+00:00\",\n",
      "  \"abstract\": \"B-type natriuretic peptide (BNP) may be a predictor of stroke risk in patients with nonvalvular atrial fibrillation (NVAF); because heart failure is associated with the incidence of stroke in AF patients. However, limited data exist regarding the association between BNP at baseline and risks of thromboembolic events (TE) and death in NVAF patients. We prospectively studied 1,013 NVAF patients (725 men, 72.8\\u00b19.7 years old) from the Hokuriku-plus AF Registry to determine the relationship between BNP at baseline and prognosis among Japanese NVAF patients. During the follow-up period (median, 751 days); 31 patients experienced TE and there were 81 cases of TE/all-cause death. For each endpoint we constructed receiver-operating characteristic curves that gave cutoff points of BNP for TE (170 pg/mL) and TE/all-cause death (147 pg/mL). Multivariate analysis with the Cox-proportional hazards model indicated that high BNP was significantly associated with risks of TE (hazard ratio [HR] 3.86; 95% confidence interval [CI] 1.83-8.67; P=0.0003) and TE/all-cause death (HR 2.27; 95% CI 1.45-3.56; P=0.0003). Based on the C-index and net reclassification improvement, the addition of BNP to CHA In a real-world cohort of Japanese NVAF patients, high BNP was significantly associated with TE and death. Plasma BNP might be a useful biomarker for these adverse clinical events.\",\n",
      "  \"data_source_name\": \"Hokuriku-Plus AF Registry\",\n",
      "  \"design_model_description\": \"Prospective registry study\",\n",
      "  \"population_follow_up\": \"Median 751 days\",\n",
      "  \"redirection_link\": \"https://pubmed.ncbi.nlm.nih.gov/29491320\",\n",
      "  \"population_sex\": [\n",
      "    \"Male\",\n",
      "    \"Female\"\n",
      "  ],\n",
      "  \"journal\": \"Circulation journal : official journal of the Japanese Circulation Society\",\n",
      "  \"design_model\": \"Cohort studies\",\n",
      "  \"summary\": \"In a real-world cohort of Japanese NVAF patients, high BNP was significantly associated with TE and death and Plasma BNP might be a useful biomarker for these adverse clinical events.\",\n",
      "  \"keywords\": [\n",
      "    \"Atrial Fibrillation\",\n",
      "    \"B Type Natriuretic Peptide\",\n",
      "    \"Thromboembolism\"\n",
      "  ],\n",
      "  \"chemicals\": [\n",
      "    \"Natriuretic Peptide, Brain\"\n",
      "  ],\n",
      "  \"population_age_group\": [\n",
      "    \"Adult\"\n",
      "  ],\n",
      "  \"pmid\": \"29491320\",\n",
      "  \"retrieved_from\": [\n",
      "    \"Semantic Scholar\",\n",
      "    \"PubMed\"\n",
      "  ],\n",
      "  \"authors\": [\n",
      "    \"Kenshi Hayashi\",\n",
      "    \"Toyonobu Tsuda\",\n",
      "    \"Akihiro Nomura\",\n",
      "    \"Noboru Fujino\",\n",
      "    \"Atsushi Nohara\",\n",
      "    \"Kenji Sakata\",\n",
      "    \"Tetsuo Konno\",\n",
      "    \"Chiaki Nakanishi\",\n",
      "    \"Hayato Tada\",\n",
      "    \"Yoji Nagata\",\n",
      "    \"Ryota Teramoto\",\n",
      "    \"Yoshihiro Tanaka\",\n",
      "    \"Masa-Aki Kawashiri\",\n",
      "    \"Masakazu Yamagishi\"\n",
      "  ],\n",
      "  \"category\": \"Publication refering to a registry\",\n",
      "  \"medical_condition\": [\n",
      "    \"Nonvalvular atrial fibrillation\"\n",
      "  ],\n",
      "  \"population_description\": \"Patients with nonvalvular atrial fibrillation (NVAF)\",\n",
      "  \"title\": \"Impact of B-Type Natriuretic Peptide Level on Risk Stratification of Thromboembolism and Death in Patients With Nonvalvular Atrial Fibrillation\\u3000- The Hokuriku-Plus AF Registry.\",\n",
      "  \"population_size\": 1013,\n",
      "  \"mesh_terms\": [\n",
      "    \"Adult\",\n",
      "    \"Aged\",\n",
      "    \"Aged, 80 And Over\",\n",
      "    \"Atrial Fibrillation\",\n",
      "    \"Disease Free Survival\",\n",
      "    \"Female\",\n",
      "    \"Follow Up Studies\",\n",
      "    \"Heart Failure\",\n",
      "    \"Humans\",\n",
      "    \"Incidence\",\n",
      "    \"Male\",\n",
      "    \"Middle Aged\",\n",
      "    \"Natriuretic Peptide, Brain\",\n",
      "    \"Proportional Hazards Models\",\n",
      "    \"Registries\",\n",
      "    \"Stroke\",\n",
      "    \"Survival Rate\",\n",
      "    \"Thromboembolism\"\n",
      "  ],\n",
      "  \"pdf_link\": \"https://www.jstage.jst.go.jp/article/circj/82/5/82_CJ-17-1085/_pdf\"\n",
      "}\n",
      "{\n",
      "  \"object_id\": \"0002cd46-647c-5323-b930-3c17531e8e33\",\n",
      "  \"outcome_measure\": \"Multimorbidity clusters and their relationship with infection severity/mortality\",\n",
      "  \"comparator\": \"Not specified\",\n",
      "  \"registry_related\": true,\n",
      "  \"geographical_area\": [\n",
      "    \"Spanish region\"\n",
      "  ],\n",
      "  \"intervention\": \"Not specified\",\n",
      "  \"publishing_date\": \"2023-01-01T00:00:00+00:00\",\n",
      "  \"abstract\": \"Several chronic conditions have been identified as risk factors for severe COVID-19 infection, yet the implications of multimorbidity need to be explored. The objective of this study was to establish multimorbidity clusters from a cohort of COVID-19 patients and assess their relationship with infection severity/mortality. The MRisk-COVID Big Data study included 14 286 COVID-19 patients of the first wave in a Spanish region. The cohort was stratified by age and sex. Multimorbid individuals were subjected to a fuzzy c-means cluster analysis in order to identify multimorbidity clusters within each stratum. Bivariate analyses were performed to assess the relationship between severity/mortality and age, sex, and multimorbidity clusters. Severe infection was reported in 9.5% (95% CI: 9.0-9.9) of the patients, and death occurred in 3.9% (95% CI: 3.6-4.2). We identified multimorbidity clusters related to severity/mortality in most age groups from 21 to 65 years. In males, the cluster with highest percentage of severity/mortality was Heart-liver-gastrointestinal (81-90 years, 34.1% severity, 29.5% mortality). In females, the clusters with the highest percentage of severity/mortality were Diabetes-cardiovascular (81-95 years, 22.5% severity) and Psychogeriatric (81-95 years, 16.0% mortality). This study characterized several multimorbidity clusters in COVID-19 patients based on sex and age, some of which were found to be associated with higher rates of infection severity/mortality, particularly in younger individuals. Further research is encouraged to ascertain the role of specific multimorbidity patterns on infection prognosis and identify the most vulnerable morbidity profiles in the community. NCT04981249. Registered 4 August 2021 (retrospectively registered).\",\n",
      "  \"data_source_name\": \"MRisk-COVID study\",\n",
      "  \"design_model_description\": null,\n",
      "  \"population_follow_up\": \"Not specified\",\n",
      "  \"redirection_link\": \"https://pubmed.ncbi.nlm.nih.gov/37651465\",\n",
      "  \"population_sex\": [\n",
      "    \"Male\",\n",
      "    \"Female\"\n",
      "  ],\n",
      "  \"journal\": null,\n",
      "  \"design_model\": \"Cohort studies\",\n",
      "  \"summary\": null,\n",
      "  \"keywords\": [],\n",
      "  \"chemicals\": [],\n",
      "  \"pmid\": \"37651465\",\n",
      "  \"population_age_group\": [\n",
      "    \"Not specified\"\n",
      "  ],\n",
      "  \"retrieved_from\": [\n",
      "    \"PubMed\"\n",
      "  ],\n",
      "  \"authors\": [\n",
      "    \"Marina Lleal\",\n",
      "    \"Celia Corral-Vazquez\",\n",
      "    \"Montserrat Bar\\u00e9\",\n",
      "    \"Ricard Comet\",\n",
      "    \"Susana Herranz\",\n",
      "    \"Francisco Baigorri\",\n",
      "    \"Antonio Gimeno-Miguel\",\n",
      "    \"Maria Raurich\",\n",
      "    \"Cristina Forti\\u00e0\",\n",
      "    \"Marta Navarro\",\n",
      "    \"Beatriz Poblador-Plou\",\n",
      "    \"Marisa Bar\\u00e9\"\n",
      "  ],\n",
      "  \"category\": \"Publication refering to a registry\",\n",
      "  \"medical_condition\": [\n",
      "    \"COVID-19\"\n",
      "  ],\n",
      "  \"population_description\": \"COVID-19 patients of the first wave in a Spanish region, stratified by age and sex\",\n",
      "  \"pdf_link\": null,\n",
      "  \"population_size\": 14286,\n",
      "  \"mesh_terms\": [\n",
      "    \"Adult\",\n",
      "    \"Aged\",\n",
      "    \"Female\",\n",
      "    \"Humans\",\n",
      "    \"Male\",\n",
      "    \"Middle Aged\",\n",
      "    \"Young Adult\",\n",
      "    \"Big Data\",\n",
      "    \"Cluster Analysis\",\n",
      "    \"Correlation Of Data\",\n",
      "    \"COVID 19\",\n",
      "    \"Multimorbidity\"\n",
      "  ],\n",
      "  \"title\": \"Multimorbidity patterns in COVID-19 patients and their relationship with infection severity: MRisk-COVID study.\"\n",
      "}\n",
      "{\n",
      "  \"object_id\": \"00031e47-1c32-5cdf-9c42-1cbb818794e7\",\n",
      "  \"outcome_measure\": null,\n",
      "  \"comparator\": null,\n",
      "  \"registry_related\": true,\n",
      "  \"geographical_area\": null,\n",
      "  \"intervention\": null,\n",
      "  \"publishing_date\": \"2020-09-23T00:00:00+00:00\",\n",
      "  \"abstract\": \"Abstract Objective: The aim of this study was to compare antithrombotic regimens following transcatheter aortic valve implantation (TAVI) in patients requiring long-term oral anticoagulation (OAC). Methods: We systematically searched PubMed, Embase, and Cochrane databases for interventional and observational studies comparing OAC to OAC plus single antiplatelet therapy (SAPT). Results: Five studies were included (four registry-based and one randomized controlled trial), comprising a total of 1318 patients. Our meta-analysis revealed lower rates of severe bleeding (pooled odds ratio [OR] 0.46 [0.31, 0.69], P<0.01, I2=0%) and major bleeding (pooled OR 0.46 [0.27,0.79], P<0.01, I2=0%) for the OAC group than for the OAC-plus-SAPT group. There was a nonsignificant trend towards reduced life-threatening bleeding events in the OAC group (pooled OR 0.54 [0.27,1.08], P=0.08, I2=11%). There was no difference between groups in the risks of stroke (pooled OR 1.02 [0.58,1.80], P=0.58, I2= 0%) or all-cause mortality (pooled OR 1.04 [0.75,1.42], P=0.83, I2= 0%) after TAVI. Conclusions: Our pooled analysis suggests that for patients with an indication for long-term OAC after TAVI, double anti-thrombotic therapy, compared to OAC alone, increased the risk of bleeding without reducing cerebrovascular events and all-cause mortality.\",\n",
      "  \"data_source_name\": \"\",\n",
      "  \"design_model_description\": null,\n",
      "  \"population_follow_up\": null,\n",
      "  \"redirection_link\": \"https://www.semanticscholar.org/paper/eff6ee74902edc473b75ff1970064adbf1764aa0\",\n",
      "  \"population_sex\": null,\n",
      "  \"journal\": \"medRxiv\",\n",
      "  \"design_model\": null,\n",
      "  \"summary\": \"For patients with an indication for long-term OAC after TAVI, double anti-thrombotic therapy, compared to OAC alone, increased the risk of bleeding without reducing cerebrovascular events and all-cause mortality.\",\n",
      "  \"keywords\": null,\n",
      "  \"chemicals\": null,\n",
      "  \"population_age_group\": null,\n",
      "  \"pmid\": null,\n",
      "  \"retrieved_from\": [\n",
      "    \"Semantic Scholar\"\n",
      "  ],\n",
      "  \"authors\": [\n",
      "    \"G. Costa\",\n",
      "    \"J. Sousa\",\n",
      "    \"L. Gon\\u00e7alves\",\n",
      "    \"R. Teixeira\"\n",
      "  ],\n",
      "  \"category\": \"Publication refering to a registry\",\n",
      "  \"medical_condition\": null,\n",
      "  \"title\": \"Antithrombotic Therapy After Transcatheter Aortic Valve Implantation in Patients with Long-Term Indication for Anticoagulation: Systematic Review and Meta-Analysis\",\n",
      "  \"population_description\": null,\n",
      "  \"population_size\": null,\n",
      "  \"mesh_terms\": null,\n",
      "  \"pdf_link\": null\n",
      "}\n",
      "{\n",
      "  \"object_id\": \"0003bfcc-a2d1-59a4-98e8-e5600a19f04b\",\n",
      "  \"outcome_measure\": null,\n",
      "  \"comparator\": null,\n",
      "  \"registry_related\": true,\n",
      "  \"geographical_area\": null,\n",
      "  \"intervention\": null,\n",
      "  \"publishing_date\": \"2009-10-01T00:00:00+00:00\",\n",
      "  \"abstract\": \"The present review provides an update on the recent literature regarding disease-specific issues in lung transplantation. Some of the published data will help refine previously published candidate selection criteria and provide evidence-based data for choice of procedures. Recent studies on lung transplant outcomes in older patients underline that satisfactory results can be obtained in patients older than 60 years but not in patients older than 70 years. Data from two large registry-based studies indicate that bilateral lung transplantation in patients with chronic obstructive pulmonary disease confers significantly longer survival than single lung transplantation, especially in patients younger than 60 years. Mathematical models to estimate survival benefit in chronic obstructive pulmonary disease lung transplant candidates have been developed and are being validated. The impact of Bcc colonization in cystic fibrosis patients on outcome has been nuanced; thus, cystic fibrosis lung transplant candidates colonized by particular Bcc strains may be transplanted with good outcomes. Novel surgical approaches to peculiar situations in end-stage cystic fibrosis have been described. Candidate selection criteria for retransplantation procedures have further been clarified. This article attempts to provide an overview of some of the currently important topics for clinicians involved in referring and evaluating patients with end-stage lung disease for lung transplantation in 2009.\",\n",
      "  \"population_follow_up\": null,\n",
      "  \"design_model_description\": null,\n",
      "  \"data_source_name\": \"\",\n",
      "  \"redirection_link\": \"https://pubmed.ncbi.nlm.nih.gov/19620868\",\n",
      "  \"population_sex\": null,\n",
      "  \"journal\": \"Current Opinion in Organ Transplantation\",\n",
      "  \"design_model\": null,\n",
      "  \"summary\": \"An update on the recent literature regarding disease-specific issues in lung transplantation is provided to provide an overview of some of the currently important topics for clinicians involved in referring and evaluating patients with end-stage lung disease for lung transplants in 2009.\",\n",
      "  \"keywords\": [],\n",
      "  \"chemicals\": [],\n",
      "  \"population_age_group\": null,\n",
      "  \"pmid\": \"19620868\",\n",
      "  \"retrieved_from\": [\n",
      "    \"Semantic Scholar\",\n",
      "    \"PubMed\"\n",
      "  ],\n",
      "  \"authors\": [\n",
      "    \"Christiane Knoop\",\n",
      "    \"Marc Estenne\"\n",
      "  ],\n",
      "  \"category\": \"Publication refering to a registry\",\n",
      "  \"pdf_link\": null,\n",
      "  \"population_description\": null,\n",
      "  \"medical_condition\": null,\n",
      "  \"population_size\": null,\n",
      "  \"mesh_terms\": [\n",
      "    \"Cystic Fibrosis\",\n",
      "    \"Humans\",\n",
      "    \"Lung Transplantation\",\n",
      "    \"Patient Satisfaction\",\n",
      "    \"Patient Selection\",\n",
      "    \"Pulmonary Disease, Chronic Obstructive\",\n",
      "    \"Treatment Outcome\"\n",
      "  ],\n",
      "  \"title\": \"Disease-specific approach to lung transplantation.\"\n",
      "}\n"
     ]
    }
   ],
   "source": [
    "import json\n",
    "from datetime import datetime\n",
    "\n",
    "\n",
    "# Custom function to handle datetime serialization\n",
    "def serialize(obj):\n",
    "    if isinstance(obj, datetime):\n",
    "        return obj.isoformat()  # Convert datetime to ISO format string\n",
    "    raise TypeError(f\"Type {type(obj)} not serializable\")\n",
    "\n",
    "\n",
    "# Access the Publication_v2 collection\n",
    "publication_collection = weaviate_client.collections.get(\"Publication_v2\")\n",
    "\n",
    "# Fetch 5 objects\n",
    "response = publication_collection.query.fetch_objects(limit=15) # , return_properties=['object_id', 'outcome_measure', 'comparator', 'registry_related', 'geographical_area', 'intervention', 'publishing_date', 'population_follow_up', 'design_model_description', 'data_source_name', 'redirection_link', 'population_sex', 'journal', 'design_model', 'summary', 'keywords', 'chemicals', 'population_age_group', 'pmid', 'authors', 'retrieved_from', 'category', 'medical_condition', 'pdf_link', 'population_size', 'mesh_terms', 'population_description'])\n",
    "\n",
    "# Print the results\n",
    "for obj in response.objects:\n",
    "    print(json.dumps(obj.properties, indent=2, default=serialize))\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "True"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "obj.properties[\"registry_related\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "ename": "TypeError",
     "evalue": "Collection.iterator() got an unexpected keyword argument 'filters'",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mTypeError\u001b[0m                                 Traceback (most recent call last)",
      "Cell \u001b[0;32mIn[9], line 3\u001b[0m\n\u001b[1;32m      1\u001b[0m \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21;01mweaviate\u001b[39;00m\u001b[38;5;21;01m.\u001b[39;00m\u001b[38;5;21;01mclasses\u001b[39;00m\u001b[38;5;21;01m.\u001b[39;00m\u001b[38;5;21;01mquery\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;28;01mimport\u001b[39;00m Filter\n\u001b[0;32m----> 3\u001b[0m \u001b[43mpublication_collection\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43miterator\u001b[49m\u001b[43m(\u001b[49m\n\u001b[1;32m      4\u001b[0m \u001b[43m    \u001b[49m\u001b[43mfilters\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mFilter\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mby_property\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mregistry_related\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[43m)\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mequal\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;28;43;01mFalse\u001b[39;49;00m\u001b[43m)\u001b[49m\n\u001b[1;32m      5\u001b[0m \u001b[43m)\u001b[49m\n",
      "\u001b[0;31mTypeError\u001b[0m: Collection.iterator() got an unexpected keyword argument 'filters'"
     ]
    }
   ],
   "source": [
    "from weaviate.classes.query import Filter\n",
    "\n",
    "publication_collection.iterator(\n",
    "    filters=Filter.by_property(\"registry_related\").equal(False)\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "from weaviate.classes.query import Filter\n",
    "\n",
    "collection = client.collections.get(\"YourCollectionName\")\n",
    "response = collection.query.fetch_objects(\n",
    "    filters=Filter.by_property(\"your_field_name\").equal(\"your_value\"),\n",
    "    limit=5\n",
    ")\n",
    "\n",
    "for o in response.objects:\n",
    "    print(o.properties)  # Inspect returned objects"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "dict_keys(['object_id', 'medical_condition', 'design_model', 'authors', 'redirection_link', 'summary', 'journal', 'keywords', 'data_source_name', 'outcome_measure', 'comparator', 'chemicals', 'registry_related', 'pmid', 'population_age_group', 'geographical_area', 'retrieved_from', 'intervention', 'category', 'pdf_link', 'population_description', 'design_model_description', 'population_size', 'mesh_terms', 'population_sex', 'publishing_date', 'population_follow_up'])"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "obj.properties.keys()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "217736\n"
     ]
    }
   ],
   "source": [
    "print(response.total_count)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "  0%|          | 101/217736 [00:00<03:47, 957.42it/s]"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|| 217601/217736 [01:51<00:00, 2366.86it/s]"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|| 217736/217736 [02:10<00:00, 2366.86it/s]"
     ]
    }
   ],
   "source": [
    "from tqdm import tqdm\n",
    "\n",
    "total_count = publication_collection.aggregate.over_all(total_count=True).total_count\n",
    "\n",
    "pbar = tqdm(total=total_count)\n",
    "\n",
    "uuids = []\n",
    "\n",
    "for item in publication_collection.iterator():\n",
    "    uuids.append(item.uuid)\n",
    "    pbar.update(1)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [],
   "source": [
    "import random\n",
    "\n",
    "random_uuid = random.sample(uuids, 300)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['__annotations__',\n",
       " '__class__',\n",
       " '__delattr__',\n",
       " '__dict__',\n",
       " '__dir__',\n",
       " '__doc__',\n",
       " '__eq__',\n",
       " '__format__',\n",
       " '__ge__',\n",
       " '__getattribute__',\n",
       " '__gt__',\n",
       " '__hash__',\n",
       " '__init__',\n",
       " '__init_subclass__',\n",
       " '__le__',\n",
       " '__lt__',\n",
       " '__module__',\n",
       " '__ne__',\n",
       " '__new__',\n",
       " '__reduce__',\n",
       " '__reduce_ex__',\n",
       " '__repr__',\n",
       " '__setattr__',\n",
       " '__sizeof__',\n",
       " '__str__',\n",
       " '__subclasshook__',\n",
       " '__weakref__',\n",
       " '_property',\n",
       " '_target',\n",
       " '_target_path',\n",
       " 'contains_any',\n",
       " 'equal',\n",
       " 'not_equal']"
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dir(Filter.by_id())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [],
   "source": [
    "from weaviate.classes.query import Filter\n",
    "\n",
    "response = publication_collection.query.fetch_objects(\n",
    "    filters=Filter.by_id().contains_any(random_uuid)\n",
    ")\n",
    "# dict_objects = [serialize(obj.properties) for obj in response.objects]\n",
    "# save as jsonl\n",
    "import io\n",
    "with io.open(\"random_publications.jsonl\", \"w\", encoding=\"utf-8\") as f:\n",
    "    for obj in response.objects:\n",
    "        f.write(json.dumps(obj.properties, default=serialize) + \"\\n\")\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'object_id': 'df3b4d1f-c532-5836-a89f-83ea9e5411e9',\n",
       " 'outcome_measure': 'Diagnostic performance of axilla ultrasound (US), breast shear wave elastography (SWE), and their combination in detecting residual metastasis in axillary level III after NAT',\n",
       " 'comparator': 'Not specified',\n",
       " 'registry_related': True,\n",
       " 'geographical_area': ['Not specified'],\n",
       " 'intervention': 'Not specified',\n",
       " 'publishing_date': datetime.datetime(2024, 11, 20, 0, 0, tzinfo=datetime.timezone.utc),\n",
       " 'abstract': \"To develop a combined approach using shear wave elastography (SWE) and conventional ultrasound (US) to determine the extent of positive axillary lymph nodes (LNs) following neoadjuvant therapy (NAT) in breast cancer patients with nodal involvement. This prospective, multicenter study was registered on the Chinese Clinical Trial Registry (ChiCTR2400085035). From October 2018 to February 2024, a total of 303 breast cancer patients with biopsy-proven positive LN were enrolled. The conventional US features of axillary LNs and SWE characteristics of breast lesions after NAT were analyzed. The diagnostic performances of axilla US, breast SWE, and their combination in detecting residual metastasis in axillary level III after NAT were assessed. Pathologically positive LN(s) in axilla level III were detected in 13.75% of cases following NAT. The kappa value for the axilla level with positive LN confirmed by surgical pathology and detected by US is 0.39 (p\\u2009<\\u20090.001). The AUC of conventional axilla US to determine the status of axilla level III LNs after NAT was 0.67, with a sensitivity of 51.52%, a specificity of 74.36%. The breast SWE displayed moderate performance for detecting residual metastasis in axilla level III following NAT, with an AUC of 0.79, sensitivity of 84.85%, and specificity of 74.36%. Compared to axilla US and breast SWE alone, the combination of axilla US with breast SWE achieved a stronger discriminatory ability (AUC, 0.86 vs 0.67 vs 0.79, p\\u2009<\\u20090.05, Delong's test) and precise calibration (X SWE outperformed conventional US in identifying the axilla levels with nodal metastasis following NAT in patients with initially diagnosed positive axilla. Furthermore, combining breast SWE with axilla US showed good diagnostic performance for detecting residual metastasis in axilla level III after NAT.\",\n",
       " 'population_follow_up': 'Not specified',\n",
       " 'design_model_description': 'Prospective, multicenter study',\n",
       " 'data_source_name': 'Chinese Clinical Trial Registry (ChiCTR2400085035)',\n",
       " 'journal': 'La Radiologia medica',\n",
       " 'population_sex': ['Not specified'],\n",
       " 'redirection_link': 'https://pubmed.ncbi.nlm.nih.gov/39565571',\n",
       " 'design_model': 'Cohort studies',\n",
       " 'summary': 'SWE outperformed conventional US in identifying the axilla levels with nodal metastasis following neoadjuvant therapy (NAT) in patients with initially diagnosed positive axilla.',\n",
       " 'keywords': ['Axilla',\n",
       "  'Breast Neoplasm',\n",
       "  'Elastography',\n",
       "  'Neoadjuvant Therapy',\n",
       "  'Ultrasound'],\n",
       " 'chemicals': [],\n",
       " 'population_age_group': ['Not specified'],\n",
       " 'pmid': '39565571',\n",
       " 'authors': ['Jia-Xin Huang',\n",
       "  'Feng-Tao Liu',\n",
       "  'Yu-Ting Tan',\n",
       "  'Xue-Yan Wang',\n",
       "  'Jia-Hui Huang',\n",
       "  'Shi-Yang Lin',\n",
       "  'Gui-Ling Huang',\n",
       "  'Yu-Ting Zhang',\n",
       "  'Xiao-Qing Pei'],\n",
       " 'retrieved_from': ['Semantic Scholar', 'PubMed'],\n",
       " 'category': 'Publication refering to a registry',\n",
       " 'medical_condition': ['Breast cancer'],\n",
       " 'title': 'Enhancing detection of high-level axillary lymph node metastasis after neoadjuvant therapy in breast cancer patients with nodal involvement: a combined approach of axilla ultrasound and breast elastography.',\n",
       " 'pdf_link': None,\n",
       " 'population_size': 303,\n",
       " 'mesh_terms': [],\n",
       " 'population_description': 'Breast cancer patients with biopsy-proven positive lymph nodes (LNs) who underwent neoadjuvant therapy (NAT)'}"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "obj.properties"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "ename": "TypeError",
     "evalue": "_FetchObjectsQueryAsync.fetch_objects() got an unexpected keyword argument 'where'",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mTypeError\u001b[0m                                 Traceback (most recent call last)",
      "Cell \u001b[0;32mIn[17], line 1\u001b[0m\n\u001b[0;32m----> 1\u001b[0m detailed_response \u001b[38;5;241m=\u001b[39m \u001b[43mpublication_collection\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mquery\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mfetch_objects\u001b[49m\u001b[43m(\u001b[49m\n\u001b[1;32m      2\u001b[0m \u001b[43m    \u001b[49m\u001b[43mwhere\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43m{\u001b[49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mid\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[43m:\u001b[49m\u001b[43m \u001b[49m\u001b[43m{\u001b[49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m$in\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[43m:\u001b[49m\u001b[43m \u001b[49m\u001b[43mrandom_uuid\u001b[49m\u001b[43m}\u001b[49m\u001b[43m}\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m      3\u001b[0m \u001b[43m    \u001b[49m\u001b[43mreturn_properties\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43m[\u001b[49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mpmid\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mtitle\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mabstract\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[43m]\u001b[49m\u001b[43m  \u001b[49m\u001b[38;5;66;43;03m# Add other properties if needed\u001b[39;49;00m\n\u001b[1;32m      4\u001b[0m \u001b[43m)\u001b[49m\n",
      "File \u001b[0;32m~/.pyenv/versions/env_more_europa_ds/lib/python3.10/site-packages/weaviate/syncify.py:23\u001b[0m, in \u001b[0;36mconvert.<locals>.sync_method\u001b[0;34m(self, __new_name, *args, **kwargs)\u001b[0m\n\u001b[1;32m     20\u001b[0m \u001b[38;5;129m@wraps\u001b[39m(method)  \u001b[38;5;66;03m# type: ignore\u001b[39;00m\n\u001b[1;32m     21\u001b[0m \u001b[38;5;28;01mdef\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21msync_method\u001b[39m(\u001b[38;5;28mself\u001b[39m, \u001b[38;5;241m*\u001b[39margs, __new_name\u001b[38;5;241m=\u001b[39mnew_name, \u001b[38;5;241m*\u001b[39m\u001b[38;5;241m*\u001b[39mkwargs):\n\u001b[1;32m     22\u001b[0m     async_func \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mgetattr\u001b[39m(\u001b[38;5;28mcls\u001b[39m, __new_name)\n\u001b[0;32m---> 23\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[43m_EventLoopSingleton\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mget_instance\u001b[49m\u001b[43m(\u001b[49m\u001b[43m)\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mrun_until_complete\u001b[49m\u001b[43m(\u001b[49m\n\u001b[1;32m     24\u001b[0m \u001b[43m        \u001b[49m\u001b[43masync_func\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;28;43mself\u001b[39;49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43margs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\n\u001b[1;32m     25\u001b[0m \u001b[43m    \u001b[49m\u001b[43m)\u001b[49m\n",
      "File \u001b[0;32m~/.pyenv/versions/env_more_europa_ds/lib/python3.10/site-packages/weaviate/event_loop.py:41\u001b[0m, in \u001b[0;36m_EventLoop.run_until_complete\u001b[0;34m(self, f, *args, **kwargs)\u001b[0m\n\u001b[1;32m     39\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mloop \u001b[38;5;129;01mis\u001b[39;00m \u001b[38;5;28;01mNone\u001b[39;00m \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mloop\u001b[38;5;241m.\u001b[39mis_closed():\n\u001b[1;32m     40\u001b[0m     \u001b[38;5;28;01mraise\u001b[39;00m WeaviateClosedClientError()\n\u001b[0;32m---> 41\u001b[0m fut \u001b[38;5;241m=\u001b[39m asyncio\u001b[38;5;241m.\u001b[39mrun_coroutine_threadsafe(\u001b[43mf\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43margs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m, \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mloop)\n\u001b[1;32m     42\u001b[0m \u001b[38;5;28;01mreturn\u001b[39;00m fut\u001b[38;5;241m.\u001b[39mresult()\n",
      "\u001b[0;31mTypeError\u001b[0m: _FetchObjectsQueryAsync.fetch_objects() got an unexpected keyword argument 'where'"
     ]
    }
   ],
   "source": [
    "detailed_response = publication_collection.query.fetch_objects(\n",
    "    where={\"id\": {\"$in\": random_uuid}},\n",
    "    return_properties=[\"pmid\", \"title\", \"abstract\"]  # Add other properties if needed\n",
    ")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "response = publication_collection.query.fetch_objects(return_properties=['object_id'])\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1000"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(response.objects)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "ename": "ModuleNotFoundError",
     "evalue": "No module named 'sentence_transformers'",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mModuleNotFoundError\u001b[0m                       Traceback (most recent call last)",
      "Cell \u001b[0;32mIn[1], line 1\u001b[0m\n\u001b[0;32m----> 1\u001b[0m \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21;01msentence_transformers\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;28;01mimport\u001b[39;00m SentenceTransformer\n",
      "\u001b[0;31mModuleNotFoundError\u001b[0m: No module named 'sentence_transformers'"
     ]
    }
   ],
   "source": [
    "from sentence_transformers import SentenceTransformer\n"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "env_more_europa_ds_3_11",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.11"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
